Paper · 4586372
Class 3 antiarrhythmic action in man. Observations from monophasic action potential recordings and amiodarone treatment.
Olsson SB and 2 others. Br Heart J, 1973. Cited by 113 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Class 3 antiarrhythmic action in man. Observations from monophasic action potential recordings and amiodarone treatment. Papers, record 4586372. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4586372
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Class 3 antiarrhythmic action in man. Observations from monophasic action potential recordings and amiodarone treatment.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Action Potentials | Major topic |
| Anti-Arrhythmia Agents | Major topic |
| Arrhythmias, Cardiac | Major topic |
| Benzofurans | Major topic |
| Aged | |
| Clinical Trials as Topic | |
| Corneal Opacity | |
| Diethylamines | |
| Electrocardiography | |
| Female | |
| Heart Atria | |
| Heart Rate | |
| Humans | |
| Iodobenzoates | |
| Male | |
| Methods | |
| Middle Aged | |
| Time Factors |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References6
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 5,485,142 | The effect of amiodarone, a new anti-anginal drug, on cardiac muscle. | Br J Pharmacol | 1970 | https://conductscience.org/library/papers/5485142 | PubMed |
| 2 | 5,149,264 | Monophasic action potentials from right atrial muscle recorded during heart catheterization. | Acta Med Scand | 1971 | https://conductscience.org/library/papers/5149264 | PubMed |
| 4 | 4,112,898 | Monophasic action potential and sinus rhythm stability after conversion of atrial fibrillation. | Acta Med Scand | 1971 | https://conductscience.org/library/papers/4112898 | PubMed |
| 5 | 5,499,024 | The effect of altered thyroid state on atrial intracellular potentials. | J Physiol | 1970 | https://conductscience.org/library/papers/5499024 | PubMed |
| 6 | 4,096,989 | [Clinical study of amiodarone in cardiac rhythmic disorders]. | Presse Med (1893) | 1970 | https://conductscience.org/library/papers/4096989 | PubMed |
| 7 | 5,033,706 | Right ventricular monophasic action potentials during regular rhythm. A heart catheterization study in man. | Acta Med Scand | 1972 | https://conductscience.org/library/papers/5033706 | PubMed |
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 113 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 9,220,176 | Amiodarone: the expanding antiarrhythmic role and how to follow a patient on chronic therapy. | Clin Cardiol | 1997 | https://conductscience.org/library/papers/9220176 | PubMed |
| 8,047,495 | New antiarrhythmic drugs in pediatric use: amiodarone. | Pediatr Cardiol | 1994 | https://conductscience.org/library/papers/8047495 | PubMed |
| 7,437,202 | Efficacy of intravenous procainamide infusion in converting atrial fibrillation to sinus rhythm. Relation to left atrial size. | Br Heart J | 1980 | https://conductscience.org/library/papers/7437202 | PubMed |
| 7,426,165 | Electrophysiological assessment of amiodarone in treatment of resistant supraventricular arrhythmias. | Br Heart J | 1980 | https://conductscience.org/library/papers/7426165 | PubMed |
| 7,259,913 | Effects of acute and chronic beta-receptor blockade on ventricular repolarisation in man. | Br Heart J | 1981 | https://conductscience.org/library/papers/7259913 | PubMed |
| 7,196,769 | Arrhythmia in hypertrophic cardiomyopathy. II: Comparison of amiodarone and verapamil in treatment. | Br Heart J | 1981 | https://conductscience.org/library/papers/7196769 | PubMed |
| 7,126,390 | Evaluation of drug-induced changes in myocardial repolarisation using the paced evoked response. | Br Heart J | 1982 | https://conductscience.org/library/papers/7126390 | PubMed |
| 7,082,498 | QT and action potential duration. | Br Heart J | 1982 | https://conductscience.org/library/papers/7082498 | PubMed |
| 6,853,721 | Acute effects of amiodarone upon the canine sinus node and atrioventricular junctional region. | J Clin Invest | 1983 | https://conductscience.org/library/papers/6853721 | PubMed |
| 4,075,214 | Anaesthesia and amiodarone. | Can Anaesth Soc J | 1985 | https://conductscience.org/library/papers/4075214 | PubMed |
1 to 10 of 18
See all 18 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4586372
GET https://conductscience.org/api/papers/v1/4586372/authors